Table 3. Associations of MetS, components and number of components of the MetS with the severity of TAC among participants with prevalent TAC.

	N (%)	Model 1*	Model 2†	Model 3‡
		Exp(β) (95% CI)	Exp(β) (95% CI)	Exp(β) (95% CI)
MetS and diabetes
Neither condition	999 (61)	1.00 (ref)	1.00 (ref)	1.00 (ref)
MetS	576 (26)	1.24 (1.03, 1.48)	1.22 (1.03, 1.44)	1.23 (1.03, 1.45)
Diabetes without MetS	68 (4)	1.25 (0.79, 1.86)	1.44 (0.93, 2.12)	1.43 (0.93, 2.10)
Diabetes with MetS	254 (13)	1.26 (0.98, 1.59)	1.42 (1.12, 1.77)	1.39 (1.09, 1.74)
Components of the MetS
Elevated BP	1468 (77)	1.69 (1.40, 2.04)	1.46 (1.22,.1.75)	1.46 (1.22, 1.75)
Low HDL	717 (38)	1.01 (0.86, 1.19)	1.07 (0.92, 1.26)	1.07 (0.90, 1.26)
High TG	607 (32)	0.98 (0.85, 1.16)	1.02 (0.86, 1.20)	0.92 (0.77, 1.09)
Impaired fasting glucose (≥100 mg/dl)	638 (34)	1.21 (1.02, 1.43)	1.28 (1.09, 1.50)	1.21 (1.03, 1.43)
Abdominal obesity	1097 (58)	1.07 (0.91, 1.27)	1.07 (0.91, 1.27)	1.01 (0.85, 1.19)
Number of components of the MetS
0	118 (6)	1.00 (ref)	1.00 (ref)	1.00 (ref)
1	406 (21)	1.38 (0.96, 1.98)	1.29 (0.92, 1.81)	1.23 (0.88, 1.72)
2	543 (29)	1.32 (0.93, 1.88)	1.28 (0.91, 1.78)	1.22 (0.88, 1.69)
3	415 (22)	1.51 (1.05, 2.17)	1.48 (1.05, 2.08)	1.43 (1.02, 2.01)
4	301 (16)	1.63 (1.12, 2.38)	1.60 (1.12, 2.27)	1.52 (1.06, 2.16)
5	114 (6)	1.82 (1.15, 2.86)	1.74 (1.13, 2.67)	1.64 (1.06, 2.53)

^*Unadjusted.

^†Adjusted for age, gender and ethnicity.

^‡Adjusted for age, gender, ethnicity, LDL, smoking and lipid-lowering medications.

Exp(β), relative difference in geometric mean TAC score compared to the reference group.